Palisade Bio closes $2.5M registered direct offering and concurrent private placement

PALISADE BIO, INC.

Raised approximately $2.5M gross via 1,052,631 shares/pre-funded warrants at $2.375/share plus 1,052,631 five-year warrants at $2.375.
Transaction closed January 4, 2023; Ladenburg Thalmann acted as exclusive placement agent.
Proceeds intended for working capital and general corporate purposes.
Offering includes registered direct (513,842 shares/pre-funded warrants) and unregistered private placement (538,789 pre-funded warrants).
Company agreed to file resale registration statement for underlying shares within 30 days.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

PALISADE BIO, INC. entered into Purchase Agreements with certain institutional and accredited investors valued at approximately $2.5 million (effective 2022-12-30).

Action: entry
Agreement: equity purchase
Counterparty: certain institutional and accredited investors
Value: approximately $2.5 million
Effective: 2022-12-30

Exact text from the filing

On December 30, 2022, Palisade Bio, Inc. (the “Company”) entered into securities purchase agreements (the “Purchase Agreements”) with certain institutional and accredited investors (the “Purchasers”), pursuant to which the Company agreed to sell and issue, in a registered direct offering, an aggregate of (i) 476,842 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a purchase price per share of $2.375, and (ii) registered prefunded warrants (the “Registered Prefunded Warrants”) to purchase up to 37,000 shares of Common Stock at a purchase price of $2.3749 per Registered Prefunded Warrant (the “Registered Offering”).

View on SEC.gov

283 material agreements filed in the last 30 days. Browse all material agreements →

PALISADE BIO, INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-000368

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.